CARDIOVASCULAR PATHOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2021-02-21 病理微人

审稿速度:2.0 | 投稿命中率:95.0
经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。

105 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2015-02-09 b2007117

审稿速度:3.0 | 投稿命中率:50.0
经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93.

404 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2019-01-23 ms9016875260525266

相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧

101 0

[GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2017-07-18 yang_guoqiang2010

有所上涨，看好未来，大家认为呢？

327 0

[GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2012-11-02 Dong

审稿速度:1.0 | 投稿命中率:25.0
经验分享：三篇都是大修，然后都被拒

370 0

[GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2011-06-29 匿名用户

偏重的研究方向：心血管;

403 0

[GetPortalCommentsPageByObjectIdResponse(id=926075, encodeId=1cb79260e563, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：去年疫情期间投稿两篇文章，审稿时间回复很快，1-1.5月，一篇按照专家意见反复修改，另一篇小修。应该是心血管病理专业文章，对口强，均已经发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=176b1539528, createdName=病理微人, createdTime=Sun Feb 21 11:32:00 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509710, encodeId=74eb509e10cd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：本人投了一篇综述，中了，有关先天性心脏病分子机制的，在当时比较有创意，小修后就收了。感觉不是很难。后来投了一篇论著，直接被拒了。Huang JB, Liu YL, Sun PW, Lv XD, Du M, Fan XM. Molecular mechanisms of congenital heart disease.Cardiovasc Pathol. 2010 Sep-Oct;19(5):e183-93., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Mon Feb 09 16:42:00 CST 2015, time=2015-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849465, encodeId=8497849465d4, content=相对不错的一个期刊，这几年if慢慢起来了，应该可以吸引到更多好文章吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a87f5414135, createdName=ms9016875260525266, createdTime=Wed Jan 23 17:29:33 CST 2019, time=2019-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539957, encodeId=b4b453995e8a, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=327, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491322, encodeId=fa404913227f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：三篇都是大修，然后都被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dong, createdTime=Fri Nov 02 10:43:00 CST 2012, time=2012-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478307, encodeId=e6664e830766, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=403, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=477150, encodeId=a9cd4e71505b, content=偏重的研究方向：心血管;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d5828544, createdName=zqz520, createdTime=Tue Jun 28 15:57:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]

2011-06-28 zqz520

偏重的研究方向：心血管;

495 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务